Author

Number of items: 186.
Article
  • Deaths involving gabapentin and pregabalin, Scotland, 2000-2024: a descriptive account. (2026) John Martin Corkery, Amira Guirguis and Fabrizio Schifano picture_as_pdf
  • Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment. (2026) Stefania Chiappini, John Martin Corkery, Amira Guirguis, Alessio Mosca, Mya Murray, Davide Arillotta, Luigi Dattoli, Giovanni Martinotti, Stefania Bonaccorso, Fabrizio Schifano and Nicolo Schifano
  • Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database. (2026) Mya Murray, Fabrizio Schifano, Stefania Chiappini, John Martin Corkery and Amira Guirguis picture_as_pdf
  • Reply to comment on: “Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists: an examination of the FAERS database”. (2026) Mya Murray, Fabrizio Schifano, Stefania Chiappini, John Martin Corkery and Amira Guirguis picture_as_pdf
  • Ketamine-related deaths registered in Scotland 2013-2024. (2026) John Martin Corkery, Amira Guirguis and Fabrizio Schifano
  • Possible eye disorders in children prenatally exposed to either methadone or buprenorphine in comparison with other medications; an examination of the Food and Drug Administration (FDA) pharmacovigilance database. (2025) Stefania Chiappini, Laura Orsolini, John Martin Corkery, Amira Guirguis, Alessio Mosca, Davide Arillotta, Giovanni Martinotti and Fabrizio Schifano picture_as_pdf
  • Deaths following illicit ketamine use in England, Wales and Northern Ireland 1999-2024: An update report to inform the reclassification debate. (2025) Jade Pullen, John Martin Corkery, Rebecca McKnight and Caroline S. Copeland
  • Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and ‘Smart Drug’ Use and Misuse. (2025) Fabrizio Schifano, Stefania Bonaccorso, Davide Arillotta, John Martin Corkery, Giuseppe Floresta, Gabriele Duccio Papanti and Amira Guirguis
  • Deaths related to the use of diarylethylamines, with a focus on the United Kingdom: a systematic review and case-series report. (2025) John Martin Corkery, Caroline S Copeland and Fabrizio Schifano
  • Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data. (2025) Stefania Chiappini, Alessio Mosca, Duccio G Papanti, John Martin Corkery, Amira Guirguis, Davide Arillotta, Giovanni Martinotti and Fabrizio Schifano picture_as_pdf
  • Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues. (2025) Fabrizio Schifano, Stefania Bonaccorso, Davide Arillotta, Amira Guirguis, John Martin Corkery, Giuseppe Floresta, Gabriele Duccio Papanti Pelletier, Norbert Scherbaum and Nicolò Schifano
  • Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT 7 and κ‐opioid receptors' molecular interactions and isosteric replacement. (2025) Giuseppe Floresta, Alberto Granzotto, Vincenzo Patamia, Davide Arillotta, Gabriele D. Papanti, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano
  • Over-the-counter Psychosis : A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis. (2025) Alessio Mosca, Stefania Chiappini, Gianluca Mancusi, Andrea Miuli, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Clara Cavallotto, John Martin Corkery, Mauro Pettorruso, Giovanni Martinotti and Fabrizio Schifano
  • Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders : A pharmacovigilance perspective. (2025) S Chiappini, A Guirguis, N Schifano, J Corkery, F Semeraro, A Mosca, G D'Andrea, G D Papanti, D Arillotta, G Floresta, G Martinotti and F Schifano
  • An Update on Deaths in the United Kingdom from 'Poppers' (Alkyl Nitrites), with a Particular Focus on 'Swallowing' Fatalities. (2025) John Martin Corkery, Caroline Copeland, Stephen Ream, Peter Streete and Fabrizio Schifano
  • Postmortem findings of organ damage in novel psychoactive substances users: a comprehensive review. (2024) Beatrice Benedetti, Celeste Conte, Eva Bergamin, Riccardo Di Santo, Gabriele Ciasca, John M Corkery, Marta Bassi, Giorgia Corli, Sabrine Bilel, Fabrizio Schifano, Matteo Marti and Fabio De-Giorgio
  • Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review. (2024) Stefania Chiappini, Pietro Domenico Gramuglia, Alessio Mosca, Clara Cavallotto, Andrea Miuli, John Martin Corkery, Amira Guirguis, Fabrizio Schifano and Giovanni Martinotti
  • Piperazine Abuse and Psychosis: A Systematic Review of the Literature. (2024) Alessio Mosca, Stefania Chiappini, Andrea Miuli, Gianluca Mancusi, Clara Cavallotto, John Martin Corkery, Livia Miotti, Mauro Pettorruso, Giovanni Martinotti and Fabrizio Schifano
  • New trends of drug abuse in custodial settings: a systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances. (2024) Stefania Chiappini, Giorgia Vaccaro, Alessio Mosca, Andrea Miuli, Gianfranco Stigliano, Giulia Stefanelli, Giulia Giovannetti, Rosalba Carullo, Giacomo d'Andrea, Francesco Di Carlo, Clara Cavallotto, Mauro Pettorruso, Gilberto Di Petta, John Martin Corkery, Amira Guirguis, Jacqueline L. Stair, Giovanni Martinotti, Seena Fazel and Fabrizio Schifano picture_as_pdf
  • Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach. (2024) Davide Arillotta, Giuseppe Floresta, G. Duccio Papanti Pelletier, Amira Guirguis, John Martin Corkery, Giovanni Martinotti and Fabrizio Schifano
  • Exploring the Association Between Suicidal Thoughts, Self-Injury, and GLP-1 Receptor Agonists in Weight Loss Treatments: Insights from Pharmacovigilance Measures and Unmasking Analysis. (2024) Amira Guirguis, Stephania Chiappini, P G Duccio Papanti, Rachel Vickers-Smith, Daniel Harris, John Corkery, Davide Arillotta, Giuseppe Floresta, Giovanni Martinotti and Fabrizio Schifano
  • Semaglutide as a Possible Calmodulin Binder: Ligand-Based Computational Analyses and Relevance to Its Associated Reward and Appetitive Behaviour Actions. (2024) Giuseppe Floresta, Davide Arillotta, Valeria Catalani, G. Duccio Papanti Pelletier, John Corkery, Amira Guirguis and Fabrizio Schifano
  • Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. (2024) Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John M Corkery, Jacqueline L Stair, Fabrizio Schifano and Amira Guirguis
  • Exploring the Nexus of Binge Eating Disorder (BED), New Psychoactive Substances (NPS), and Misuse of Pharmaceuticals: Charting a Path Forward. (2023) Stefania Chiappini, G. Duccio Papanti Pelletier, Rachel Vickers-Smith, John Corkery, Amira Guirguis, Giovanni Martinotti and Fabrizio Schifano
  • GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. (2023) Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano
  • Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. (2023) Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, G. Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Giovanni Martinotti, Stefano L. Sensi and Fabrizio Schifano
  • Ibogaine/Noribogaine in the treatment of Substance Use Disorders: a systematic review of the current literature. (2023) Alessio Mosca, Stefania Chiappini, Andrea Miuli, Gianluca Mancusi, Maria Chiara Santovito, Francesco Di Carlo, Mauro Pettorruso, John Corkery, Carlos Canessa, Giovanni Martinotti and Massimo Di Giannantonio
  • In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines. (2023) Valeria Catalani, Giuseppe Floresta, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Vincenzo Abbate and Fabrizio Schifano
  • First death involving 4-Fluoroethylphenidate (4F-EPH): case-report, user experiences, and review of the related literature. (2022) John Martin Corkery and Fabrizio Schifano picture_as_pdf
  • Hearing Impairment in Children Living with HIV in Haiti. (2022) Vienna Valeriani, Ankita Patro, Nathaniel Segaren, Daphnee Michel, Anaelle Canez, Shaina Lamour, Patrick J. Gilles, Sophia Charles, John Martin Corkery, James L. Netterville and Asitha D.L. Jayawardena description
  • Knowledge and use of over-the-counter drugs in Italy: a survey-based study in the general population. (2022) Stephania Chiappini, Franca Ceci, Alessio Mosca, Francesco Di Carlo, Julius Burkauskas, Mauro Pettorruso, Giovanni Martinotti, Amira Guirguis, John Martin Corkery, Norbert Scherbaum, Fabrizio Schifano and Massimo di Giannantonio
  • Alprazolam-related deaths in Scotland, 2004-2020. (2022) John Martin Corkery, Amira Guirguis, Stefania Chiappini, Giovanni Martinotti and Fabrizio Schifano picture_as_pdf
  • Designer Benzodiazepines’ Activity on Opioid Receptors: A Docking Study. (2022) Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento and Fabrizio Schifano
  • Contribution of drugs to drownings in Scotland, 1996-2020. (2022) John Corkery, Giovanni Martinotti and Fabrizio Schifano
  • Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS). (2022) Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Daniel R. Harris and Fabrizio Schifano
  • A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases. (2022) Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti and Fabrizio Schifano
  • Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals. (2022) Fabrizio Schifano, Valeria Catalani, Safia (Sophia) Sharif, Flavia Napoletano, John Corkery, Davide Arillotta, Suzanne Fergus, Alessandro Vento and Amira Guirguis
  • Misuse of anticholinergic medications: a systematic review. (2022) Stefania Chiappini, Alessio Mosca, Andrea Miuli, Francesco Semeraro, Gianluca Mancusi, Maria Chiara Santovito, Francesco Di Carlo, Mauro Pettorruso, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Fabrizio Schifano and Massimo di Giannantonio picture_as_pdf
  • Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019. (2021) John Martin Corkery, Wang-Chu Hung, Hugh Claridge, Christine Goodair, Caroline S. Copeland and Fabrizio Schifano picture_as_pdf
  • Psychonauts’ psychedelics: a systematic, multilingual, web-crawling exercise. (2021) Valeria Catalani, John Martin Corkery, Amira Guirguis, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Alessandro Vento and Fabrizio Schifano
  • The psychonauts’ benzodiazepines; quantitative structure-activity relationship (QSAR) analysis and docking prediction of their biological activity. (2021) Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum and Fabrizio Schifano description
  • Covid-19 pandemic impact on substance misuse: a social media listening, mixed method analysis. (2021) Davide Arillotta, Amira Guirguis, John Martin Corkery, Norbert Scherbaum and Fabrizio Schifano
  • New Psychoactive Substances and suicidality: a systematic review of the current literature. (2021) Stefania Chiappini, Alessio Mosca, A. Miuli, Monica Chiara Santovito, Laura Orsolini, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Giovanni Martinotti, Massimo di Giannantonio and Fabrizio Schifano description
  • Focus on over-the-counter drugs’ misuse; a systematic review on antihistamines, cough medicines and decongestants. (2021) Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, Monica Chiara Santovito, Alessio Mosca, Maria Chiara Santovito, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Massimo di Giannantonio and Giovanni Martinotti
  • New Psychoactive Substances (NPS) and Serotonin Syndrome onset: a Systematic Review. (2021) Fabrizio Schifano, Stephania Chiappini, John Corkery, Norbert Scherbaum, Flavia Napoletano, Davide Arillotta, Valeria Catalani, Alessandro Vento, Mauro Pettorruso, Giovanni Martinotti, Massimo di Giannantonio and Amira Guirguis
  • The e-psychonaut drugs’ psychopharmacology. (2021) Fabrizio Schifano, Stephania Chiappini, John Martin Corkery, Norbert Scherbaum and Amira Guirguis
  • Treatment of kratom use disorder with a classical tricyclic antidepressant: A case report and review. (2021) Alessandro Vento, Simone de Persis, Sergio De Filippis, Fabrizio Schifano, Flavia Napoletano, John Martin Corkery and Georgios D. Kotzalidis
  • Identifying new/emerging psychoactive substances at the time of COVID-19; a web-based approach. (2021) Valeria Catalini, Davide Arillotta, John Martin Corkery, Amira Guirguis, Alessandro Vento and Fabrizio Schifano description
  • The benzydamine experience: A systematic review of Benzydamine abuse. (2021) Stephania Chiappini, Andrea Miuli, Alessio Mosca, Mauro Pettorruso, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Massimo di Giannantonio and Fabrizio Schifano
  • Beyond the Purple Drank. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports. (2021) Stefania Chiappini, Fabrizio Schifano, John Martin Corkery and Amira Guirguis
  • Misuse of prescription and over-the-counter drugs to obtain illicit highs: how pharmacists can prevent abuse. (2020) Stefania Chiappini, Amira Guirguis, John Corkery and Fabrizio Schifano
  • Alcohol/substance use and occupational/post-traumatic stress in paramedics. (2020) Andrew Hichisson and John Corkery
  • The psychonauts' world of cognitive enhancers. (2020) Flavia Napoletano, Fabrizio Schifano, John Martin Corkery, Amira Guirguis, Davide Arillotta, Caroline Zangani and Alessandro Vento picture_as_pdf
  • COVID-19: The hidden impact on mental health and drug addiction. (2020) Stefania Chiappini, Amira Guirguis, Ann John, John Corkery and Fabrizio Schifano description
  • Novel opioids: systematic web crawling within the e-psychonauts’ scenario. (2020) Davide Arillotta, Fabrizio Schifano, Flavia Napoletano, Caroline Zangani, Liam Gilgar, Amira Guirguis, John Martin Corkery, E Aguglia and alessandro vento
  • Exploring the baseline knowledge and experience of healthcare professionals in the United Kingdom on Novel Psychoactive Substances. (2020) Amira Guirguis, Nigel Smeeton, Hadar Zaman, Anne-Marie Felice, Stephanie Bancroft, Rosalind Gittins, Gill Hawksworth, John Corkery and Fabrizio Schifano picture_as_pdf
  • The e-psychonauts’ ‘Spiced’ World; assessment of the synthetic cannabinoids’ information available online. (2020) Caroline Zangani, Fabrizio Schifano, Flavia Napoletano, Davide Arillotta, Liam Gilgar, Amira Guirguis, John Martin Corkery, Orsola Gambini and Alessandro Vento
  • Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of Novel Psychoactive Substances. (2020) Elena Deligianni, Omari-Jordan Daniel, John Corkery, Fabrizio Schifano and Lisa Lione description
  • Novel psychoactive substances (NPS) – knowledge and experiences of drug users from Hungary, Poland, the UK and the USA. (2020) Agnieszka Pisarska, Paolo Deluca, Zsolt Demetrovics, John Corkery, Jacek Moskalewicz, ReDNet Group, Ornella Corazza, John Corkery, Jacqueline Stair, Suzanne Fergus, Cinzia Pezzolesi and Fabrizio Schifano
  • Focus on clozapine withdrawal- and misuse-related cases, as reported to the European Medicines Agency (EMA) pharmacovigilance database. (2020) Stephania Chiappini, Fabrizio Schifano, John Martin Corkery and Amira Guirguis description
  • How deaths can help clinicians and policy-makers understand the risks of Novel Psychoactive Substances. (2020) John Corkery, Fabrizio Schifano and Giovanni Martinotti
  • 'New/Designer Benzodiazepines': an analysis of the literature and psychonauts’ trip reports. (2020) Laura Orsolini, John Corkery, Stephania Chiappini, Amira Guirguis, Alessandro Vento, Domenico De Berardis, Duccio Papanti and Fabrizio Schifano
  • Commentary on: Attafi IM, Albeishy MY, Oraiby ME, Khardali IA, Shaikhain GA, Fageeh MM. Postmortem Distribution of Cathinone and Cathine in Human Biological Specimens in a Case of Death Associated with Khat Chewing. Arab J Forensic Sci Forensic Med. 2018 Jun 7;1(7). (2019) John Corkery, Fabrizio Schifano and Amira Guirguis description
  • The use of new psychoactive substances (NPS) in young people and their role in mental health care : a systematic review. (2019) Laura Orsolini, Stephania Chiappini, John Corkery, Amira Guirguis, Duccio Papanti and Fabrizio Schifano
  • The bridge between classical and ‘synthetic’/chemical psychoses: towards a clinical, psychopathological and therapeutic perspective. (2019) Laura Orsolini, Stephania Chiappini, Duccio Papanti, Domenico De Berardis, John Martin Corkery and Fabrizio Schifano description
  • The clinical challenges of synthetic cathinones. (2019) Fabrizio Schifano, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Liam Gilgar, Amira Guirguis, John Corkery and Alessandro Vento
  • Characteristics of deaths associated with kratom use. (2019) John Corkery, Peter Streete, Hugh Claridge, Christine Goodair, Duccio G. Papanti, Laura Orsolini, Fabrizio Schifano, Kanav Sikka, Sophie Körber and Amy Hendricks
  • Use of Medicinal Cannabis and Synthetic Cannabinoids in Posttraumatic Stress Disorder (PTSD): a systematic review. (2019) Laura Orsolini, Stefania Chiappini, Umberto Volpe, Domenico De Berardis, Roberto Latini, Gabriele Duccio Papanti and John Corkery
  • New/emerging psychoactive substances and associated psychopathological consequences. (2019) Fabrizio Schifano, Flavia Napoletano, Stephania Chiappini, Amira Guirguis, John Corkery, Stefania Bonaccorso, Angelo Ricciardi, Norbert Scherbaum and alessandro vento
  • New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues. (2019) Fabrizio Schifano, Flavia Napoletano, Stephania Chiappini, Laura Orsolini, Amira Guirguis, John Martin Corkery, Stefania Bonaccorso, Angelo Ricciardi, Norbert Scherbaum and alessandro vento
  • An Insight into Z-Drug Abuse and Dependence : An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions. (2019) Fabrizio Schifano, Stefania Chiappini, John Martin Corkery and Amira Guirguis description
  • Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems. (2019) Fabrizio Schifano, Stephania Chiappini, John Corkery and Amira Guirguis picture_as_pdf
  • Post-traumatic stress and substance misuse; neurobiological and clinical pharmacological correlates. (2018) Fabrizio Schifano, Gabriele Duccio Papanti, John Corkery and Laura Orsolini description
  • An index of fatal toxicity for new psychoactive substances. (2018) L.A. King and John Corkery
  • Psychedelic Fauna for Psychonaut Hunters : A Mini-Review. (2018) Laura Orsolini, Michela Ciccarese, Duccio Papanti, Domenico De Berardis, Amira Guirguis, John Corkery and Fabrizio Schifano picture_as_pdf
  • Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. (2018) Fabrizio Schifano, Stefania Chiappini, John Corkery and Amira Guirguis description
  • Factors impacting antiretroviral therapy adherence among human immunodeficiency virus-positive adolescents in Sub-Saharan Africa: a systematic review. (2018) Nadine Ammon, Susanna Mason and John Corkery
  • Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances : A Comeback to the Shamanism? (2017) Laura Orsolini, Paul St John-Smith, Daniel McQueen, Duccio Papanti, John Corkery and Fabrizio Schifano
  • The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review. (2017) Laura Orsolini, Duccio Papanti, Domenico De Berardis, Amira Guirguis, John Corkery and Fabrizio Schifano
  • Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom communities associated with GHB and precursors. (2017) John M Corkery, Barbara Loi, Hugh Claridge, Christine Goodair and Fabrizio Schifano
  • Mortality related to new substances of abuse in the UK. (2017) John Corkery
  • An exploratory study of information sources and key findings on UK cocaine-related deaths. (2017) John Corkery, Hugh Claridge, Christine Goodair and Fabrizio Schifano
  • 4,4’-dimethylaminorex (‘4,4’-DMAR’; ‘Serotoni’) misuse; a web-based study. (2017) Barbara Loi, Mire Zloh, Maria Antonietta, John Corkery and Fabrizio Schifano
  • From concept(ion) to life after death/the grave: the ‘natural’ history and life-cycle(s) of Novel Psychoactive Substances (NPS). (2017) Laura Orsolini, John Corkery, Duccio Papanti and Fabrizio Schifano
  • Intended and Unintended Use of Cathinone Mixtures. (2017) Amira Guirguis, John Corkery, Jacqueline Stair, Stewart Kirton, Mire Zloh and Fabrizio Schifano
  • An insight into the deep web; why it matters for addiction psychiatry? (2017) Laura Orsolini, Duccio Papanti, John Corkery and Fabrizio Schifano
  • A matter of life and death : substance-caused and substance-related fatalities in Ibiza in 2015. (2017) Rita Santacroce, Claudia Ruiz Bennasar, Juan Ramon Sancho Jaraiz, Federica Fiori, Fabiola Sarchione, Federica Angelini, Gabriella Catalano, Maria Luisa Carenti, John Martin Corkery, Fabrizio Schifano, Massimo di Giannantonio and Giovanni Martinotti
  • Is there a potential of misuse for Magnolia officinalis compounds/metabolites? (2017) Fabrizio Schifano, Valentina Guarino, Duccio G. Papanti, Jacopo Baccarin, Laura Orsolini and John M. Corkery
  • An international survey on the awareness, use, preference and health perception of Novel Psychoactive Substances (NPS). (2017) Elena Deligianni, John Corkery, Fabrizio Schifano and Lisa Lione
  • Cannabis; epidemiological, neurobiological and psychopathological issues: an update. (2017) Maria Antonietta De Luca, Gaetano Di Chiara, Cristina Cadoni, Daniele Lecca, Laura Orsolini, Duccio Papanti, John Corkery and Fabrizio Schifano
  • Use of benzylglycinamide by a HIV-seropositive polysubstance user: : the changing pattern of novel psychoactive substance use among youths. (2016) Matteo Caloro, Giuseppa Calabro, Georgios D. Kotzalidis, Ilaria Cuomo, John Martin Corkery, Alessandro Emilio Vento, Luana Lionetto, Sergio De Filippis, Valentina Ranieri, Davide Lonati, Carlo Alessandro Locatelli, Eleonora de Pisa, Antonio Di Tommaso, Paolo Girardi and Fabrizio Schifano picture_as_pdf
  • Novel Psychoactive Substances: : the pharmacology of stimulants and hallucinogens. (2016) Fabrizio Schifano, Duccio Papanti, Laura Orsolini and John Corkery
  • Gli Psiconauti: navigatori della mente o sperimentatori chimici? (2016) Laura Orsolini, Roberta Vecchiotti, Duccio Papanti, Alessandro Valchera, John Corkery and Fabrizio Schifano picture_as_pdf
  • The characteristics of deaths involving kratom in the United Kingdom and elsewhere. (2016) John Corkery, Hugh Claridge, Christine Goodair, Duccio Papanti, Laura Orsolini, Sophie Koerber and Fabrizio Schifano picture_as_pdf
  • The consequences of drug misuse on post-marketing surveillance. (2016) Fabrizio Schifano, Duccio Papanti, Laura Orsolini and John Corkery picture_as_pdf
  • Novel psychoactive substances. (2016) Laura Orsolini, Duccio Papanti, Roberta Vecchiotti, Alessandro Valchera, John Corkery and Fabrizio Schifano picture_as_pdf
  • Deaths of individuals aged 16-24 years in the UK after using mephedrone. (2015) Barbara Loi, John Corkery, Hugh Claridge, Christine Goodair, Stephania Chiappini, Carla Gimeno Clemente and Fabrizio Schifano
  • Methoxetamine-related deaths in the UK : an overview. (2015) Stephania Chiappini, Hugh Claridge, John Corkery, Christine Goodair, Barbara Loi and Fabrizio Schifano
  • Venlafaxine as the ‘baby ecstasy’? : Literature overview and analysis of web-based misusers’ experiences. (2015) Giulia Francesconi, Laura Orsolini, John Corkery, Duccio Papanti and Fabrizio Schifano picture_as_pdf
  • Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists. (2015) Amira Guirguis, John Corkery, Jacqueline Stair, Stewart Kirton, Mire Zloh, Christine Goodair, Fabrizio Schifano and Colin Davidson
  • Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4 butanediol (1,4-BD; BDO) : a literature review with a focus on UK fatalities related to non-medical use. (2015) John Corkery, Barbara Loi, Hugh Claridge, Christine Goodair, Ornella Corazza, Simon Elliott and Fabrizio Schifano
  • Novel psychoactive substances of interest for psychiatry. (2015) Fabrizio Schifano, Laura Orsolini, Duccio Papanti and John Corkery
  • "Spice", "Kryptonite", "Black Mamba": An overview of brand names and marketing stragtegies of Novel Psychoactive Substances on the Web. (2014) Ornella Corazza, G. Valeriani, F. S. Bersani, John Corkery, Giovanni Martinotti, Giuseppe Bersani and Fabrizio Schifano
  • Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse. (2013) A.E. Vento, Fabrizio Schifano, Federica Gentili, Francesco Pompei, John Corkery, Georgios D. Kotzalidis and Paolo Girardi picture_as_pdf
  • Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances (NPS) in the EU : the outcomes of the ReDNet project. (2013) Ornella Corazza, Sulaf Assi, Pierluigi Simonato, John Corkery, Saverio Bersani, Zsolt Demetrovics, Jacqueline Stair, Suzanne Fergus, Cinzia Pezzolesi, Manuela Pasinetti, Paolo Deluca, C. Drummond, Ursula Blaszko, Jacek Moskalewicz, Barbara Mervo, Lucia Di Furia, Magi Farre, Liv Flesland, Agnieszka Pisarska, Harry Shapiro, Holger Siemann, Arvid Skutle, Elias Sferrazza, Marta Torrens, Farran Sambola, Peer van der Kreeft, Norbert Scherbaum and Fabrizio Schifano
  • Loss of materials and resources for addiction researchers : comment on Mitchell et al. (2012). (2013) John Corkery picture_as_pdf
  • The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine) : A brief review. (2012) John Corkery, E. Durkin, S. Elliott, Fabrizio Schifano and A. Hamid Ghodse
  • Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, meow meow) in the United Kingdom. (2012) Fabrizio Schifano, John Corkery and A.Hamid Ghodse picture_as_pdf
  • 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) : A preliminary review. (2012) John Corkery, Fabrizio Schifano, A. Hamid Ghodse, S. Elliott and Ornella Corazza
  • Phenomenon of new drugs on the Internet : the case of ketamine derivative methoxetamine. (2012) Ornella Corazza, Fabrizio Schifano, Pierluigi Simonato, Suzanne Fergus, Sulaf Assi, Jacqueline Stair, John Corkery, Giuseppina Trincas, Paolo Deluca, Zoe Davey, Ursula Blaszko, Zsolt Demetrovics, Jacek Moskalewicz, Aurora Enea, Giuditta di Melchiorre, Barbara Mervo, Lucia Di Furia, Magi Farre, Liv Flesland, Manuela Pasinetti, Cinzia Pezzolesi, Agnieszka Pisarska, Harry Shapiro, Holger Siemann, Arvid Skutle, Aurora Enea, Giuditta di Melchiorre, Elias Sferrazza, Marta Torrens, Peer van der Kreeft, Daniela Zummo and Norbert Scherbaum picture_as_pdf
  • Response to commentaries. (2011) John Corkery
  • Novel Drugs, Novel Solutions : Exploring the potential of technological tools for prevention of drug abuse. (2011) Ornella Corazza, Sulaf Assi, John Corkery, Guisippena Trincas, Per-Luigi Simonato and Zoe Davey picture_as_pdf
  • 'Bundle of fun' or 'bunch of problems'? : Case series of khat-related deaths in the UK. (2011) John Corkery, Fabrizio Schifano, Adenekan Oyefeso, A. Hamid Ghodse, Thomy Tonia, Vinesha Naidoo and Jennifer Button picture_as_pdf
  • Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997 - 2007. (2011) G. Zamparutti, Fabrizio Schifano, John Corkery, A. Oyefeso and A. Hamid Ghodse picture_as_pdf
  • Mephedrone (4-methylmethcathinone; 'meow meow') : chemical, pharmacological and clinical issues. (2011) Fabrizio Schifano, Antonio Albanese, Suzanne Fergus, Jacqueline Stair, Paolo Deluca, Ornella Corazza, Zoe Davey, John Corkery, Holger Siemann, Norbert Scherbaum, Magi' Farre', Marta Torrens, Zsolt Demetrovics and A. Hamid Ghodse picture_as_pdf
  • Overview of literature and information on "khat-related" mortality: a call for recognition of the issue and further research. (2011) John Corkery, Fabrizio Schifano, Adenekan Oyefeso, A. Hamid Ghodse, Thomy Tonia, Vinesha Naidoo and Jennifer Button
  • Suicide verdicts as opposed to accidental deaths in substance-related fatalities (UK, 2001–2007). (2011) A.E. Vento, M. Pompili, Fabrizio Schifano, John Corkery, M. Innamorati, P. Girardi and H. Ghodse picture_as_pdf
  • Overview of amphetamine-type stimulant mortality data – UK, 1997–2007. (2010) Fabrizio Schifano, John Corkery, Vinesha Naidoo, Adenekan Oyefeso and Hamid Ghodse
  • Two UK suicides using nicotine extracted from tobacco employing instructions available on the Internet. (2010) John Corkery, J. Button, A.E. Vento and Fabrizio Schifano
  • Trapped in the "K-hole" : overview of deaths associated with ketamine misuse in the UK (1993-2006). (2008) Fabrizio Schifano, John Corkery, Adenekan Oyefeso, Thomy Tonia and Abdol Hamid Ghodse picture_as_pdf
  • Smokable ( ice , crystal meth ) and non smokable amphetamine-type stimulants: clinical pharmacological and epidemiological issues, with special reference to the UK. (2007) Fabrizio Schifano, John Corkery and G. Cuffolo
  • Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003). (2006) Fabrizio Schifano, John Corkery, A. Oyefeso and A. Hamid Ghodse
  • Fatal injuries while under the influence of psychoactive drugs: a cross-sectional exploratory study in England. (2006) A. Oyefeso, Fabrizio Schifano, H. Ghodse, K. Cobain, R. Dryden and John Corkery
  • Review of deaths related to taking ecstasy, England and Wales, 1997-2000. (2003) Fabrizio Schifano, A. Oyefeso, L. Webb, M. Pollard, John Corkery and A. Hamid Ghodse
  • Approaches to the Study of English Forename Use. (2000) John Corkery
  • UK drug-related mortality – issues in definition and classification. (2008) John Corkery
  • Continuing the epidemiological function of the Addicts Index - evidence from matching the Home Office Addicts Index with the National Drug Treatment Monitoring System. (2004) M. Hickman, M. Griffin, J. Mott, John Corkery, P. Madden, A. Sondhi and G. Stimson
  • MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; ‘sparkle’; ‘mindy’) toxicity : a brief overview and update. (2013) John Corkery, Simon Elliott, Fabrizio Schifano, Ornella Corazza and Abdol Hamid Ghodse
  • Nowe substancje psychoaktywne : potrzeby informacyjne młodzieży I profesjonalistów New psychoactive substancesthe youth and professionals informational needs. (2013) Agnieszka Pisarska, Jacek Moskalewicz, Ornella Corazza, Sulaf Assi, Pierluigi Simonato, John Corkery, Zsolt Demetrovics, Jacqueline Stair, Suzanne Fergus, Cinzia Pezzolesi, Manuela Pasinetti, Paolo Deluca, Colin Drummond, Ursula Blaszko, Barbara Mervo, Lucia Di Furia, Magi Farre, Liv Flesland, Harry Shapiro, Holger Siemann, Arvid Skutle, Marta Torrens, Farran Sambola, Peer van der Kreeft, Norbert Scherbaum and Fabrizio Schifano
  • 5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'. (2012) C. T. Gallagher, S. Assi, J. L. Stair, S. Fergus, Ornella Corazza, John Corkery and Fabrizio Schifano
  • The effects of methadone and its role in fatalities. (2004) John Corkery, Fabrizio Schifano, A. Hamid Ghodse and Adenekan Oyefeso
  • Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002. (2003) Fabrizio Schifano, A. Oyefeso, John Corkery, K. Cobain, R. Jambert-Gray, G. Martinotti and A. Hamid Ghodse
  • Phenazepam abuse in the UK : an emerging problem causing serious adverse health problems, including death. (2012) John Martin Corkery, Fabrizio Schifano and Abdol Hamid Ghodse
  • Cocaine/crack cocaine consumption, treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990-2004). (2008) Fabrizio Schifano and John Corkery
  • Suicide among drug addicts in the UK. (1999) A. Oyefeso, A. Hamid Ghodse, C. Clancy and John Corkery
  • Estimating prevalence of problematic drug use: comments on Frischer et al. (2002) John Corkery
  • Khat: A Bundle of Fun or a Bunch of Problems? (2009) Jennifer Button, John Corkery and David W. Holt
  • The relationship between notification to the Home Office Addicts Index and deaths of notified addicts. (2002) John Corkery
  • Legal highs: safe and legal heavens? : A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. ["Legal highs": paradisi sicuri e legali? Uno studio sulla diffusione, conoscenza e consapevolezza del rischio delle nuove droghe psicoattive tra gli studenti del Regno Unito]. (2014) Ornella Corazza, Pierluigi Simonato, John Corkery, Giuseppina Trincas and Fabrizio Schifano
  • Le nuove sostanze psicoattive: problematiche cliniche e farmacologiche The novel psychoactive substances: clinical and pharmacological issues. (2016) Fabrizio Schifano, Laura Orsolini, Duccio Papanti and John Corkery
  • An index of fatal toxicity for drugs of misuse. (2010) L.A. King and John Corkery
  • Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002. (2005) Fabrizio Schifano, John Corkery, Eilish Gilvarry, Paolo Deluca, Adenekan Oyefeso and A. Hamid Ghodse
  • New trends in the cyber and street market of recreational drugs? : The case of 2C-T-7 ('Blue Mystic'). (2005) Fabrizio Schifano, Paolo Deluca, Lisa Agosti, Giovanni Martinotti, John Corkery, Baldacchino Alex, Bonan Caterina, Bothas Heikki, Brigada Raffaella, Comacchio Anna, Di Furia Lucia, Duarte Rui Eastwood Dorte, Farré Magi, Ferreira Susana, Flores Irene, Guionnet Claude, Harder Lisbet, Stokholm Jensen Lene, Leoni Mauro, Littlejohn Christopher, Majava Aino, Peltoniemi Teuvo, Pizza Milena, Rawaf Salman, Robert Damien, Rossi Maria Angela, Rovetto Francesco, Scherbaum Norbert, Siemann Holger, Tarrago Josep, Torrens Marta, Zambello Francesco and Psychonaut 2002 Research Group
  • Drug abuse-related mortality: a study of teenage addicts over a 20-year period. (1999) A. Oyefeso, A. Hamid Ghodse, C. Clancy, John Corkery and R. Goldfinch
    • Book Section
  • Synthetic Cannabinoids, the largest and most diverse group of novel psychoactive substances. (2024) P G Duccio Papanti, Laura Orsolini, John Martin Corkery, Stefania Chiappini, Amira Guirguis, Alessando Vento and Fabrizio Schifano picture_as_pdf
  • Substance Use Disorders and Violence. (2020) Fabrizio Schifano, Caroline Zangani, Stephania Chiappini, Amira Guirguis, Stefania Bonaccorso and John Corkery description
  • Ibogaine as a treatment for substance misuse : Potential benefits and practical dangers. (2018) John Martin Corkery picture_as_pdf
  • Synthetic cathinones – prevalence and motivations for use. (2018) John Corkery, Amira Guirguis, Duccio Papanti, Laura Orsolini and Fabrizio Schifano
  • NPS: Medical Consequences Associated with Their Intake. (2016) Fabrizio Schifano, Laura Orsolini, Duccio Papanti and John Corkery description
  • Mephedrone-related fatalities in the United Kingdom : contextual, clinical and practical issues. (2012) John Corkery, Fabrizio Schifano and Abdol H Ghodse
  • UK fatalities associated with caffeine : Annex 3. (2012) John Corkery
  • Decessi ed altri indicatori chiave del consume di cocaine nel Regno Unito (1990-2004). (2006) Fabrizio Schifano and John Corkery picture_as_pdf
    • Monograph
  • Descriptive research into large-scale user data from an established alcohol identification and brief advice (IBA) intervention website. (2024) Dylan Andrew Kerr and John Martin Corkery
  • Trends in UK deaths associated with abuse of volatile substances, 1971-2009. (2012) A. Hamid Ghodse, John Corkery, Kapil Ahmed and Fabrizio Schifano
  • Drug-related deaths in the UK: Annual Report 2011 [January-December 2010] : Drug-related deaths reported by Coroners in England, Wales, Northern Ireland, Guernsey, Jersey and the Isle of Man; Police forces in Scotland; & the Northern Ireland Statistics and Research Agency. (2012) A. Hamid Ghodse, John Corkery, Fabrizio Schifano, Antonio Piolanti, Giuseppina Trincas and Giuditta Di Melchiorre
    • Conference or Workshop Item
  • Concentrations of mephedrone in cases of fatal and non-fatal clinical intoxications. (2017) E. Papaseit, E. Olesti, R. de la Torre, John Corkery, Marta Torrens and Farré Magi
  • Novel Psychoactive Substance (NPS) awareness, use and health perception following The UK Psychoactive Substances Act 2016. (2017) Elena Deligianni, Omari-Jordan Daniel, John Corkery, Fabrizio Schifano and Lisa Lione
  • A systematic review of a clinical intervention in the treatment of acute myocardial infarction in the Gulf region. (2016) Hessah Alaslawi and John Corkery
  • EU-MADNESS: integrated EU NPS monitoring and profiling to prevent health harms and update Professionals. (2014) John Corkery
  • Recent developments concerning the DRD Key Indicator in United Kingdom. (2014) John Corkery
  • 'Defining, measuring and monitoring Drug-Related Deaths in national and sub-national contexts: the example of the United Kingdom'. (2002) John Corkery
    • Book
  • Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon. (2019) Ornella Corazza, Robert Chilcott, Giovanni Martinotti, John Corkery, Amira Guirguis, Mire Zloh, Shanna Marrinan and Valeria Catalani
    • Report
  • Analysis of the data sources, numbers and characteristics of cocaine-related DRD cases reported in Special Mortality Registries, or eventually in General Mortality Registries (GMR) when necessary : A Report for the European Monitoring Centre for Drugs and Drug Addiction. (2012) John Corkery picture_as_pdf
    • Other
  • The use of health warning labels to discourage sugar-sweetened beverage consumption by children. (2021) Michelle Leon, Zoe Aslanpour and John Martin Corkery
  • The use of interactive technology an effective training method to improve combined strength and balance in community-dwelling older adults: a systematic review. (2021) Fiona Deans, John Marftin Corkery and Susanna Mason
  • An investigation into the relationship(s) between the different chemical classes of synthetic cathinones and their effects: desired, adverse and toxic. (2017) John Corkery, Amira Guirguis, Laura Orsolini, Duccio Papanti and Fabrizio Schifano
  • Substance use and misuse - Legal highs. (2016) Amira Guirguis, Rosalind Gittins, John Corkery and Fabrizio Schifano picture_as_pdf
  • ‘Legal highs’ – a health warning that does not appear on the wrapper. (2011) John Corkery
  • Legal highs : a problem of definitions? (2014) Christine Goodair, John Corkery and Hugh Claridge
  • Factors Impacting on the Evolution and Characteristics of UK Deaths Involving‘Traditional’ and ‘New’ Stimulants. (2013) John Corkery and Fabrizio Schifano
  • Methoxetamine: An Analogue of Ketamine. (2013) Stephania Chiappini, Hugh Claridge, John Corkery, Carla Gimeno Clemente, Christine Goodair, Barbara Loi and Fabrizio Schifano
  • The Unregulated Psychoactive Compound: ‘Benzo Fury’. (2013) Carla Gimeno Clemente, Stephania Chiappini, Hugh Claridge, John Corkery, Christine Goodair, Barbara Loi and Fabrizio Schifano
  • UK deaths associated with ‘Z’ drugs (Zopiclone, Zolpidem & Zaleplon). (2013) Salvatore Casula, Hugh Claridge, John Corkery, Carla Gimeno Clemente, Christine Goodair, Barbara Loi and Fabrizio Schifano
  • Drug-related deaths in the UK: January-December 2012 : Annual report 2013. (2014) John Corkery, Hugh Claridge, Barbara Loi, Christine Goodair and Fabrizio Schifano
  • United Kingdom drug situation: annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2014 : Contributed to Chapter 6: Health correlates and consequences. (2014) John Corkery
  • Drug-related deaths in the UK : Annual Report 2012. (2013) A. Hamid Ghodse, John Corkery, Hugh Claridge, Christine Goodair and Fabrizio Schifano
  • Cathinone-related mortality: khat, mephedrone and related novel psychoactive substances and their role in deaths – the UK experience. (2012) John Corkery
  • Public health consequences of khat use. (2008) John Corkery
  • Fatalities Associated with Mephedrone in Combination with Other Stimulant Drugs in Young People Aged 16-24 Years. (2013) Barbara Loi, Stephania Chiappini, Hugh Claridge, John Corkery, Carla Gimeno Clemente, Christine Goodair and Fabrizio Schifano
  • ‘Special M’ related fatalities in the UK. (2014) Stephania Chiappini, Hugh Claridge, John Corkery, Christine Goodair, Barbara Loi and Fabrizio Schifano
  • The evolution and characteristics of UK deaths involving GHB and its analogues. (2014) John Corkery, Barbara Loi, Hugh Claridge, Christine Goodair, Ornella Corazza, Simon Elliott and Fabrizio Schifano
  • Chapter 6: Health correlates and consequences. (2013) Layla English, John Corkery and Vivian Hope
  • Monitoring and profiling the characteristics of Novel Psychoactive Substances and their consumers in the context of the EU-MADNESS project. (2015) John Corkery
  • How many drug addicts are there? (2008) John Corkery
  • Chapter 7: Responses to health correlates and consequences. (2013) Layla English, Vivian Hope and John Corkery
  • Global Survey on Novel Psychoactive Substances & Effects of Ketamine in Lower Urinary tract. (2016) Elena Deligiani , John Corkery and Lisa Lione
    • This list was generated on Tue May 19 02:39:05 2026 BST.